Atlas Trials

A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma

Clinical trial NCT01308723 · COMPLETED

Trial details

NCT number
NCT01308723
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Carcinoma, Hepatocellular
Start date
2011-03-01
Primary completion
2012-01-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.